Literature DB >> 16876972

Investigation of microemulsion system for transdermal delivery of meloxicam.

Yue Yuan1, San-ming Li, Feng-kui Mo, Da-fang Zhong.   

Abstract

A new oil-in-water microemulsion containing 0.375% meloxicam was developed in order to improve the skin permeability of meloxicam. Among various surfactants and cosurfactants investigated in the microemulsion system, polyoxyethylene sorbitan trioleate (Tween 85) showed excellent solubility and ethanol expressed skin permeation enhancing effect for meloxicam. The microemulsion existence ranges were defined through the construction of the pseudo-ternary phase diagram. The effect of the content of isopropyl myristate (IPM) and the effect of the mass ratio of the surfactant/cosurfactant (Km) on skin permeation of meloxicam were evaluated with excised rat skins. The optimum formulation with the highest skin permeation rate (5.40 microg/cm2/h) consisted of 0.375% meloxicam, 5% IPM, 50% Tween 85/ethanol (1:1) and water.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876972     DOI: 10.1016/j.ijpharm.2006.06.021

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  24 in total

1.  Nanoemulsion components screening and selection: a technical note.

Authors:  Adnan Azeem; Mohammad Rizwan; Farhan J Ahmad; Zeenat Iqbal; Roop K Khar; M Aqil; Sushama Talegaonkar
Journal:  AAPS PharmSciTech       Date:  2009-01-16       Impact factor: 3.246

2.  Design and formulation technique of a novel drug delivery system for azithromycin and its anti-bacterial activity against Staphylococcus aureus.

Authors:  M Joyce Nirmala; Amitava Mukherjee; N Chandrasekaran
Journal:  AAPS PharmSciTech       Date:  2013-06-26       Impact factor: 3.246

3.  Development and evaluation of new microemulsion-based hydrogel formulations for topical delivery of fluconazole.

Authors:  Georgeta Coneac; Vicenţiu Vlaia; Ioana Olariu; Ana Maria Muţ; Dan Florin Anghel; Cornelia Ilie; Călin Popoiu; Dumitru Lupuleasa; Lavinia Vlaia
Journal:  AAPS PharmSciTech       Date:  2015-01-16       Impact factor: 3.246

4.  Formulation of microemulsion systems for dermal delivery of silymarin.

Authors:  Vipaporn Panapisal; Sawitree Charoensri; Angkana Tantituvanont
Journal:  AAPS PharmSciTech       Date:  2012-02-16       Impact factor: 3.246

5.  Development of w/o microemulsion for transdermal delivery of iodide ions.

Authors:  Hao Lou; Ni Qiu; Catherine Crill; Richard Helms; Hassan Almoazen
Journal:  AAPS PharmSciTech       Date:  2012-12-19       Impact factor: 3.246

6.  Microemulsion system with improved loading of piroxicam: a study of microstructure.

Authors:  Muhammad Faizan Nazar; Asad Muhammad Khan; Syed Sakhawat Shah
Journal:  AAPS PharmSciTech       Date:  2009-10-30       Impact factor: 3.246

7.  Nanocarrier for the transdermal delivery of an antiparkinsonian drug.

Authors:  Adnan Azeem; Farhan J Ahmad; Roop K Khar; Sushama Talegaonkar
Journal:  AAPS PharmSciTech       Date:  2009-09-09       Impact factor: 3.246

8.  Nanoemulgel, an Innovative Carrier for Diflunisal Topical Delivery with Profound Anti-Inflammatory Effect: in vitro and in vivo Evaluation.

Authors:  Mehreen Bashir; Junaid Ahmad; Muhammad Asif; Salah-Ud-Din Khan; Muhammad Irfan; Asim Y Ibrahim; Sajid Asghar; Ikram Ullah Khan; Muhammad Shahid Iqbal; Abdul Haseeb; Syed Haroon Khalid; Mohammed As Abourehab
Journal:  Int J Nanomedicine       Date:  2021-02-22

9.  Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studies.

Authors:  Lidiane M Monteiro; Viviane F Lione; Flavia A do Carmo; Lilian H do Amaral; Julianna H da Silva; Luiz E Nasciutti; Carlos R Rodrigues; Helena C Castro; Valeria P de Sousa; Lucio M Cabral
Journal:  Int J Nanomedicine       Date:  2012-09-28

10.  Transdermal agomelatine microemulsion gel: pyramidal screening, statistical optimization and in vivo bioavailability.

Authors:  Mayada Said; Ibrahim Elsayed; Ahmed A Aboelwafa; Ahmed H Elshafeey
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.